DrugPatentWatch Database Preview

Mobius Therap Company Profile

« Back to Dashboard

What is the competitive landscape for MOBIUS THERAP, and when can generic versions of MOBIUS THERAP drugs launch?

MOBIUS THERAP has one approved drug.

There are five US patents protecting MOBIUS THERAP drugs.

There are nine patent family members on MOBIUS THERAP drugs in five countries.

Summary for Mobius Therap

International Patents:	9
US Patents:	5
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Mobius Therap

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes	9,539,241		Y	Y
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes	9,205,075		Y
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes	7,806,265		Y
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes	9,649,428
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes	8,186,511		Y

International Patents for Mobius Therap Drugs

Country	Patent Number	Estimated Expiration
Japan	5448071
Japan	5670546
Japan	2014097399
European Patent Office	2046653
European Patent Office	3175843
Australia	2007272514

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Mobius Therap